Shanghai trial of nifedipine in the elderly (STONE)

Journal of Hypertension

Volumn 14, Issue 10, 1996, Pages 1237-1245

  Gong, Lansheng ^a   Zhang, Weizhong ^a   Zhu, Yijun ^a   Zhu, Junren ^b   Kong, Dewen ^c   Pagé, Véronique ^c   Ghadirian, Parviz ^c   LeLorier, Jacques ^c   Hamet, Pavel ^c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Elderly; Hypertension; Nifedipine; Placebo controlled trial; Stroke

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADULT; AGED; ARTICLE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; SINGLE BLIND PROCEDURE; STROKE;

EID: 0029830418     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199610000-00013     Document Type: Article

References (34)

1. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994, 23:275-285.
2. Gagnon F, Dagenais GR, Robitaille NM, Lupien PJ: Impact of systolic and diastolic blood pressure on ischemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol 1994, 10:97-105
3. Larochelle P: Hypertension in the elderly. Cardiovasc Drugs Ther 1990, 4 (suppl 5):947-950.
4. Carruthers SG, Larochelle P Haynes RB, Petrasovits A, Schiffrin EL: Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. Can Med Assoc J 1993, 149:289-293.
5. Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al.: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985, i:1349-1354.
6. Fletcher A, Amery A, Birkenhager W, Bulpitt C, Clement D, de Leeuw P, et al.: Risk and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1991, 9:225-230
7. SHEP Cooperative Research Group: Prevention of stroke by anti-hypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264.
8. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish trial in patients with hypertension (STOP-Hypertension). Lancet 1994, 338:1281-1285.
9. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1994, 304:405-412.
10. Black HR: Therapeutic considerations in the elderly hypertension: the role of calcium channel blockers. Am J Hypertens 1990, 3 (suppl):347S-354S.
11. Applegate W, Philipps HL, Schnaper H, Shepherd AMM, Schocken D, Luhr JC, et al.: A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991, 151:1817-1823.
12. Hall WD: Hypertension in the elderly with a special focus on treatment with angiotensin-converting enzyme inhibitors and calcium antagonists. Am J Cardiol 1992, 69:33E-42E.
13. Applegate WB, Miller ST, Elam JT, Cushman WC, Derwi DE, Brewer A, et al.: Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med 1992, 152:1162-1166.
14. Gong L, Zhang W, Zhu Y: Prospective study of the effect of nifedipine on the cardiovascular complications in elderly hypertensives [abstract]. J Hypertens 1992, 10 (suppl 4):S132.
15. The Shanghai Collaborative Groups of Intervention Trial on Elderly Hypertensive Patients: A prospective study of treatment of elderly hypertension with nifedipine in the prevention of complications [in Chinese]. Chin J Cardiol 1992, 20:5.
16. Gong L, Zhang W, Zhu Y, Zhu J, Pagé V, Ghadirian P, et al.: Shanghai trial of nifedipine in the elderly (STONE) [abstract]. Seventh European Meeting on Hypertension, Milan, Italy, June 9-12 1995. Milan: Università degli Studi di Milano; 1995:370.
17. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunathan TE, Weiss NS, et al.: The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995, 274:620-625
18. Zanchetti A, Chalmers J, Arakawa K, Gyarias I, Hamet P, Hansson L, et al.: 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993, 11:905-918.
19. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G: Prevalence, control and awareness of high blood pressure among Canadian adults. Can Med Assoc J 1992, 146:1997-2005.
20. Gong LS, Zhang WZ, Wang H: Traditions of antihypertensive therapy in different countries: China. In Handbook of Experimental Pharmacology: Pharmacology of Antihypertensive Therapeutics. Edited by Ganten D, Mulrow PJ. Berlin: Springer-Verlag; 1990:848-853.
21. Schulz KF, Chalmers J, Hayes RJ, Attman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412.
22. Coope J, Warrender TS: Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986, 293:1145-1151.
23. Sackett DL: Rules of evidence and clinical recommendations on use of antithrombotic agents. Chest 1989, 95 (suppl 2):2S-4S.
24. National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group report on hypertension and chronic renal failure. Arch Intern Med 1991, 151:1280-1287.
25. Hypertension Detection and Follow-up Program, Cooper Group: Five-year findings of the Hypertension Detection and Follow-up Program: II. Mortality by race, sex and age. JAMA 1979, 242:2572-2577.
26. Wu YK: Epidemiology and community control of hypertension, stroke and coronary heart disease in China. Chinese Med J 1979, 92:665-670.
27. MacMahon S, Rodgers A: Blood pressure, antihypertensive treatment and stroke risk. J Hypertens 1994, 12 (suppl 10):S5-S14.
28. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Nealon J, et al.: Blood pressure, stroke, and coronary heart disease - part 1. Prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 1990, 335:765-774.
29. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al.: Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context Lancet 1990, 335:827-838.
30. MacMahon S, Rodgers A: The epidemiological association between blood pressure and stroke: implications for primary and secondary prevention. Hypertens Res 1994, 17 (suppl 1):S23-S32.
31. Lever AF, Ramsay LE: Treatment of hypertension in the elderly. J Hypertens 1995, 13:571-579.
32. Denke MA, Grundy SM: Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann J Intern Med 1990, 112:780-792.
33. Goldman L, Weinstein MC, Goldman PA, Williams LW: Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991, 265:1145-1151.
34. Spence JD, Hachinski VC: Neurological complications of hypertension. In Handbook of Clinical Neurology, Volume 19(3): Systemic Diseases: Part 1. Edited by Goetz CG, Tanner CM, Aminoff MJ. Amsterdam: Elsevier Sciences Publishers; 1993:71-91.